packageIrinotecan

irinotecan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Irinotecan is a topoisomerase I inhibitor used as an anticancer medicine, mainly for colorectal and pancreatic cancers and also for several other cancers such as lung, breast, stomach and brain tumours. It remains in use, is authorised in the European Union, and is included on the WHO list of essential medicines.

Summary written by glm-5.3-flash from Wikidata Q412197 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:irinotecan
ATC codes:L01CE02, L01XX19
DrugBank:DB00762
PubChem CID:60838
ChEBI:80630
Wikidata:Q412197
formula:C33H38N4O6
molar mass:586.689 g/mol (PubChem CID 60838)
logP:3 (Drugs.Common 25.09, not verified)

Metabolites

SN38SN-38392.411 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
SN38metabolite: SN-38